Malm J, Laurell M, Dahlbäck B
Department of Clinical Chemistry, University of Lund, Malmö General Hospital, Sweden.
Br J Haematol. 1988 Apr;68(4):437-43. doi: 10.1111/j.1365-2141.1988.tb04232.x.
The plasma concentrations of protein S, protein C and C4b-binding protein (C4BP) were analysed during pregnancy, in the postpartum period and in women using oral contraceptives. Free protein S, measured after precipitation of the C4BP-protein S complexes with 5% PEG 6000, was found to be 8.3 mg/l in the control group, which represents 36.3% of the total plasma protein S content (average 23.5 mg/l). The concentration of protein S was significantly decreased during pregnancy, the lowest levels occurring in the second trimester (14.8 mg/l). The values returned to normal within a few days after delivery. The concentration of free protein S was also decreased, down to an average of 3.7 mg/l at delivery, and did not return to normal within the first week postpartum. The mean concentration of protein S in women using oral contraceptives decreased to 17.7 mg/l and the free fraction went down to 6.6 mg/l. Unlike that of protein S, the plasma concentration of protein C increased during pregnancy, reaching a maximum of 135% in the second trimester. Also, it was significantly higher in the postpartum period and in women using oral contraceptives, than in controls. The level of C4BP was increased throughout pregnancy, with a maximum of 143.4% at delivery. These changes in the plasma levels of proteins C and S during pregnancy indicate that the two proteins differ in the regulation of their synthesis. The major decrease in the level of free protein S may predispose to thrombotic episodes during pregnancy, whereas the increased level of protein C may have the reverse effect. These results indicate the importance of taking into account the normal changes in the plasma levels of protein C and S during pregnancy and the use of oral contraceptives, when evaluating patients with increased risk of thromboembolic disease.
对孕期、产后及使用口服避孕药的女性的血浆蛋白S、蛋白C和C4b结合蛋白(C4BP)浓度进行了分析。用5%聚乙二醇6000沉淀C4BP - 蛋白S复合物后测得的游离蛋白S在对照组中为8.3mg/L,占血浆总蛋白S含量(平均23.5mg/L)的36.3%。孕期蛋白S浓度显著降低,在孕中期最低(14.8mg/L)。产后几天内数值恢复正常。游离蛋白S浓度也降低,分娩时平均降至3.7mg/L,产后第一周内未恢复正常。使用口服避孕药的女性蛋白S平均浓度降至17.7mg/L,游离部分降至6.6mg/L。与蛋白S不同,孕期血浆蛋白C浓度升高,在孕中期达到最高值135%。此外,产后及使用口服避孕药的女性中,其浓度显著高于对照组。孕期C4BP水平持续升高,分娩时最高达143.4%。孕期蛋白C和蛋白S血浆水平的这些变化表明这两种蛋白在合成调节方面存在差异。游离蛋白S水平的大幅下降可能使孕期易发生血栓形成事件,而蛋白C水平升高可能具有相反作用。这些结果表明,在评估血栓栓塞性疾病风险增加的患者时,考虑孕期及使用口服避孕药期间血浆蛋白C和蛋白S水平的正常变化非常重要。